Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

31st May 2018 14:35

RNS Number : 8894P
Vectura Group plc
31 May 2018
 

 

 

 

VECTURA GROUP PLC (the "Company")

 

 

Chippenham, UK - 31 May 2018: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled product formulation, device design and development business, announces that Frank Condella, Non-Executive Director, joined the Board of Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company with effect from 30 May 2018.

This information is disclosed to the London Stock Exchange in accordance with the requirements under paragraph 9.6.14R of the United Kingdom Listing Rules relating to the disclosure of changes to the roles, functions and responsibilities of directors.

 

- Ends -

 

 

 

Enquiries

 

Vectura Group plc

+44 (0)20 7881 0524

John Murphy

Company Secretary

Consilium Strategic Communications

+44 (0)20 3709 5700

Mary-Jane Elliott / Susan Stuart/ Jessica Hodgson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNFMGFKFMZGRZM

Related Shares:

VEC.L
FTSE 100 Latest
Value8,275.66
Change0.00